Challenges and opportunities from targeting inflammatory responses to SARS-CoV-2 infection: a narrative review

V Lariccia, S Magi, T Serfilippi, M Toujani… - Journal of Clinical …, 2020 - mdpi.com
The novel coronavirus disease 2019 (COVID-19) is a global pandemic that continues to
sweep across the world, posing an urgent need for effective therapies and prevention of the …

NSAIDs for early management of acute respiratory infections

M Bassetti, M Andreoni, P Santus… - Current Opinion in …, 2024 - journals.lww.com
The inflammatory response plays a pivotal role in the early phase of acute respiratory tract
infections (ARTIs); a correct diagnosis of the cause and a prompt therapeutic approach with …

Risk of SARS‐CoV‐2 Infection and COVID‐19 Severity Associated With Exposure to Nonsteroidal Anti‐Inflammatory Drugs: Systematic Review and Meta‐Analysis

L Prada, C D. Santos, RA Baião, J Costa… - The Journal of …, 2021 - Wiley Online Library
Nonsteroidal anti‐inflammatory drugs (NSAIDs) were thought to increase the severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus entrance into cells. Hence, it was …

[PDF][PDF] FEVER in children: recommendations for primary care doctors: FEVER COMPASS

Z Doniec, T Jackowska, A Sybilski, J Woroń… - Family Medicine & …, 2021 - termedia.pl
In children, fever is a symptom of a wide spectrum of diseases, ranging from common self-
limiting viral upper respiratory tract infections to serious life-threatening diseases. The aim of …

[HTML][HTML] Are Healthcare Resource Utilization Patterns for Pain Management Specific to Post-Acute COVID-19 Syndrome? A Study of Survivors from the First French …

M Dziadzko, M Belhassen, E Van Ganse… - Journal of Clinical …, 2024 - mdpi.com
Objectives: Chronic pain is a common symptom in Post-Acute COVID-19 Syndrome (PACS),
affecting 11–60% of patients, but the link between COVID-19 and chronic pain remains …

Coronavirus disease 2019: A comprehensive review on recent clinical updates and management tools for pharmacists

BD Bhargab, B Dash, A Newar… - Pharmaceutical …, 2021 - pharmabiosciencejournal.com
In the Hubei region of China, a pneumonia outbreak occurred in December 2019, which was
confirmed to be caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Comparison of the analgesic effects of intravenous infusion of Dexmedetomidine versus bilateral superficial cervical plexus block after thyroidectomy: a randomized …

J Xing, R Wu, L Liang, H Fang, L Chen… - The Clinical Journal of …, 2021 - journals.lww.com
Objectives: Dexmedetomidine (DEX) is widely used in clinical practice because of its safety
and effectiveness. Superficial cervical plexus block (SCPB) can reduce pain in thyroid …

[HTML][HTML] Uso de resúmenes de evidencia para informar el tratamiento farmacológico de personas con sospecha o diagnóstico de infección respiratoria por SARS-CoV …

N Yomayusa González, E Low Padilla… - Revista Colombiana …, 2020 - scielo.org.co
Introducción: debido a la emergencia del coronavirus SARS-CoV-2 desde diciembre del
2019, se ha generado un gran volumen de producción científica, en algún caso incierta o …

Host-informed therapies for the treatment of pneumococcal pneumonia

B Sundaresh, S Xu, B Noonan, MK Mansour… - Trends in Molecular …, 2021 - cell.com
Over the past two decades, traditional antimicrobial strategies have lost efficacy due to a
rapid rise in antibiotic resistance and limited success in developing new antibiotics. Rather …

[PDF][PDF] Precauciones al indicar antiinflamatorios no esteroideos para controlar el dolor dental en pacientes con COVID-19

BEF Guerrero, GSF Pasapera - Revista Cubana de Estomatología, 2021 - medigraphic.com
Por su mecanismo de acción, los AINEs presentan efectos adversos frecuentes, como
trastornos digestivos (gastritis o úlceras digestivas) y trastornos renales (insuficiencia renal …